Promimic AB
AZ BioVentureHub, HB4
c/o AstraZeneca R&D Mölndal
Mölndal
431 83
Tel: 46-0-31-16-08-60
Website: http://www.promimic.com/
Email: info@promimic.com
About Promimic AB
Promimic is a biomaterial company founded in 2004 as a spin-off from research performed at Chalmers University of Technology in Gothenburg, Sweden. The company develops and markets a new generation of implant surface modifications and synthetic bone based on a patented method for production of nano sized hydroxyapatite. Promimic has an innovative and experienced organization that continuously is working on new ways to improve surface modification and coating of new materials.YEAR FOUNDED:
2004
LEADERSHIP:
CEO: Ulf Brogren
JOBS:
Please click here for Promimic job opportunities.
PRODUCTS:
All Products
4 articles about Promimic AB
-
Onkos Surgical® Announces Partnership with Promimic AB for Development of Hydroxyapatite Surface Technology in Limb Salvage Surgery
3/14/2019
Onkos Surgical, Inc. announced today that it has partnered with Promimic AB, the world's leading innovator in nano surface modification, to commercialize Promimic's proprietary Hydroxyapatite (HA) Surface Technologies in Limb Salvage Surgery.
-
Karolinska Development AB Release: Company Portfolio Company Promimic AB Appoints Magnus Larsson As New CEO And Launches US Sales Operation
1/18/2017
-
Karolinska Development AB Portfolio Company Promimic AB And Danco Announce Completion Of U.S. Production Line For Hanano Surface Medical Implant Coating
10/19/2016
-
Karolinska Development AB Portfolio Company Promimic AB Raises SEK 23.8 Million To Establish Commercial Operations In The U.S.
9/13/2016